Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in ...

Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...

Tesla boss Elon Musk seems to be on a mission to conquer the world, and even Mars. But his odd-hour rants, alleged Nazi ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...

A Cleveland Clinic psychiatrist on how ketamine therapy is transforming depression treatment—and why it works when other options fall short.

Johnson & Johnson (NYSE:JNJ) is currently addressing shareholder proposals regarding executive compensation and human rights ...

The analyst identified the finding as eliminating “the need for frequent re-dosing seen with JNJ's Spravato." He argued that the commercial success of JNJ's ketamine-based therapy could support ...